The Kidney Cancer Program (KCP), jointly led by urologist Nirmish Singla and oncologist Yasser Ged, was established with the goal of offering world-class, multidisciplinary clinical care and cutting-edge collaborative research “to continuously improve the care of patients with kidney tumors around the world,” says Singla. “Our KCP team brings together expertise from Urology, Medical Oncology, Radiation Oncology, Nephrology, Pathology, Radiology, Immunology, Engineering, Statistics, and Epidemiology.” The program features six research subprograms, encompassing grant-funded clinical and translational research across the spectrum of kidney cancer. “We provide excellent, compassionate, personalized, multidisciplinary care for localized, locally advanced, and metastatic disease.”